LIVE

Serial Number

79143061

Owner

ALK-Abelló A/S

Attorney

B. Brett Heavner

Filing Date

Oct 14, 2013

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

AVANZ Trademark

Serial Number: 79143061 • Registration: 4701835

AVANZ is a trademark filed by ALK-Abelló A/S on October 14, 2013. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Class 42 - Computer & Scientific

Scientific and technological services; industrial analysis and research services

Class 44 - Medical Services

Medical services; veterinary services; hygienic and beauty care for human beings or animals

Owner Contact Info

ALK-Abelló A/S (37 trademarks)

Bøge Allé 6-8
DK-2970 Hørsholm , DK

Entity Type: 99

Legal Representation

Attorney of Record

B. Brett Heavner

2,882 trademarks filed View all →

Trademark Details

Filing Date

October 14, 2013

Registration Date

March 17, 2015

Published for Opposition

December 30, 2014

Cancellation Date

October 13, 2023

Goods & Services

Pharmaceutical preparations, namely, pharmaceutical preparations for immunotherapeutic purposes, and pharmaceutical preparations for diagnosing, prevention and treatment of allergies, allergic rhinitis, allergic asthma and asthma; diagnostic preparations for medical purposes

Medical services and medical consultations in the field of immunotherapy, allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases; providing patient support, namely, providing information, advice and consultation to patients in the field of immunotherapy and the prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases; providing a website featuring information for patients in the field of immunotherapy and the prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases; providing information to medical professionals relating to immunotherapy and the diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases; providing a website featuring information for medical professionals relating to immunotherapy and the diagnosis, prevention and treatment of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases; medical diagnosis of allergy, asthma, allergic rhinitis and allergic asthma as well as respiratory allergic diseases

Medical research; scientific research; industrial analysis and research services in the nature of laboratory services, namely, laboratory research in the field of allergy and asthma

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

May 12, 2024 DENC

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

May 12, 2024 DENA

DEATH OF INTERNATIONAL REGISTRATION

May 12, 2024 DETH

TOTAL INVALIDATION PROCESSED BY THE IB

Oct 2, 2022 INNT

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

Sep 6, 2022 INTS

INVALIDATION PROCESSED

Sep 6, 2022 INPC

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Jul 26, 2022 INTR

CANCELLED SECTION 71

Nov 26, 2021 C71T

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

Mar 17, 2020 REM3

NEW REPRESENTATIVE AT IB RECEIVED

Jan 23, 2020 NREP

NEW REPRESENTATIVE AT IB RECEIVED

Sep 15, 2016 NREP

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 15, 2015 FINO

FINAL DISPOSITION NOTICE SENT TO IB

Jul 29, 2015 FICS

FINAL DISPOSITION PROCESSED

Jul 29, 2015 FIMP

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jun 17, 2015 FICR

REGISTERED-PRINCIPAL REGISTER

Mar 17, 2015 R.PR

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Dec 30, 2014 NPUB

PUBLISHED FOR OPPOSITION

Dec 30, 2014 PUBO

NOTIFICATION PROCESSED BY IB

Dec 27, 2014 GPNX

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 10, 2014 OPNS

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 10, 2014 OP2R

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 10, 2014 NONP

ASSIGNED TO EXAMINER

Dec 1, 2014 DOCK

LAW OFFICE PUBLICATION REVIEW COMPLETED

Nov 25, 2014 PREV

APPROVED FOR PUB - PRINCIPAL REGISTER

Nov 24, 2014 CNSA

EXAMINER'S AMENDMENT ENTERED

Nov 18, 2014 XAEC

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Nov 18, 2014 GNEN

EXAMINERS AMENDMENT E-MAILED

Nov 18, 2014 GNEA

EXAMINERS AMENDMENT -WRITTEN

Nov 18, 2014 CNEA

NOTIFICATION OF FINAL REFUSAL EMAILED

Aug 27, 2014 GNFN

FINAL REFUSAL E-MAILED

Aug 27, 2014 GNFR

FINAL REFUSAL WRITTEN

Aug 27, 2014 CNFR

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 11, 2014 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 11, 2014 CRFA

ASSIGNED TO LIE

Aug 5, 2014 ALIE

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Aug 4, 2014 TROA

REFUSAL PROCESSED BY IB

Mar 28, 2014 RFNT

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Mar 11, 2014 RFCS

REFUSAL PROCESSED BY MPU

Mar 11, 2014 RFRR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Mar 11, 2014 RFCR

NON-FINAL ACTION WRITTEN

Mar 10, 2014 CNRT

APPLICATION FILING RECEIPT MAILED

Mar 4, 2014 MAFR

ASSIGNED TO EXAMINER

Mar 1, 2014 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 28, 2014 NWOS

LIMITATION FROM ORIGINAL APPLICATION ENTERED

Feb 28, 2014 LIMI

SN ASSIGNED FOR SECT 66A APPL FROM IB

Feb 27, 2014 REPR

Related Trademarks

More from this Owner

KLARIFY

ALK LIFE SCIENCE SOLUTIONS

More in Same Class

CHERRY BOMB

TENGION NEO-EGI

DEXCEL PHARMA

TENGION NEO-GI

Serial #86090902

COLOPLAST